What is Whole Cell-SELEX? SELEX (Systematic Evolution of Ligands by EXponential enrichment) is a technique used to develop aptamers—single-stranded DNA or RNA oligonucleotides that bind to a specific target molecule with high affinity and specificity, akin to antibodies. Whole Cell-SELEX is a variant where the target is not a purified protein, but an entire living cell. This is crucial for discovering aptamers against: Native cell-surface proteins in their natural conformation and modification state. Complex membrane protein complexes. Disease-specific cell markers (e.g., on cancer cells, pathogens) without prior knowledge of the specific molecular target. Specific cell types in a heterogeneous mixture (e.g., cancer stem cells within a tumor). A service provider performs this technically demanding and iterative process on behalf of researchers or companies. The Core Process of a Whole Cell-SELEX Service A typical service workflow involves close collaboration with the client: 1. Project Design & Consultation Defining Targets: Client specifies the positive selection cell (e.g., human glioblastoma cells) and the critical negative/counter selection cell (e.g., normal astrocytes or a related cell line). This is key to generating selective aptamers. Library Design: The service provider uses a vast (10^14 - 10^15 sequences) random oligonucleotide library. 2. The SELEX Cycle (Iterative Rounds) This is the core experimental phase performed by the service provider: Incubation: The library is incubated…
What is Whole-cell SELEX? Whole-cell SELEX (Systematic Evolution of Ligands by EXponential enrichment) is a technique used to discover aptamers (single-stranded DNA or RNA molecules) that bind specifically to a target living cell. Unlike traditional SELEX that uses a purified protein target, whole-cell SELEX presents the target in its native, complex cellular environment. This allows for the selection of aptamers against: Native cell-surface proteins in their proper folding and post-translational modifications. Complex targets like transmembrane receptors in their natural lipid environment. Unknown surface biomarkers without prior knowledge of the cell's molecular makeup. Specific cell states (e.g., activated, cancerous, infected) based on differences in surface expression. The Core Process: How Whole-cell SELEX Works A professional service will manage this complex, iterative pipeline: Library & Design: Starting with a vast, random synthetic oligonucleotide library (10^14 - 10^15 unique sequences). Positive Selection: Incubating the library with the target cells (e.g., cancer cells, stem cells, bacteria). Aptamers that bind to any surface structure are retained. Counter-Selection (Critical Step): The bound pool is then exposed to non-target or control cells (e.g., healthy cells, a different cell line). Sequences that bind to these are discarded. This step is crucial for generating specificity. Elution & Amplification: Aptamers specifically bound to the target cells are recovered, amplified by PCR…
Aptamer Capture-SELEX Service refers to a specialized, outsourced process where a company or academic core facility performs the entire Capture-SELEX procedure to develop DNA or RNA aptamers for a client's specific target molecule. This is a crucial service for researchers and companies who need high-affinity, specific aptamers but lack the specialized equipment, expertise, or time to run the SELEX process in-house. Let's break down what this service entails. 1. What is Capture-SELEX? First, understand the standard SELEX (Systematic Evolution of Ligands by EXponential enrichment). It's an iterative process to select aptamers from a vast random oligonucleotide library (10^14 - 10^15 different sequences). Capture-SELEX is a specific variant designed primarily for small molecules or targets that are difficult to immobilize directly on a solid support without affecting their structure/function. The Key Difference: Instead of immobilizing the target itself, a short, complementary "capture strand" is immobilized on beads or a surface. The initial ssDNA library is designed with a region complementary to this capture strand. The target is free in solution. How it Works: The library is bound to the surface via the capture strand. The target molecule is introduced in solution. Only library sequences that fold into a structure capable of binding the target will undergo a conformational change. This binding event often weakens or…
